Craig B Whitman

Summary

Publications

  1. doi request reprint Cephalosporin-induced leukopenia following rechallenge with cefoxitin
    Craig B Whitman
    Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA 19104, USA
    Ann Pharmacother 42:1327-32. 2008
  2. doi request reprint Possible case of nafcillin-induced acute interstitial nephritis
    Craig B Whitman
    Philadelphia College of Pharmacy, University of the Sciences, 600 South 43rd Street, Philadelphia, PA 19104, USA
    Am J Health Syst Pharm 69:1049-53. 2012
  3. doi request reprint Fidaxomicin for the treatment of Clostridium difficile infections
    Craig B Whitman
    Philadelphia College of Pharmacy, University of the Sciences, PA, USA
    Ann Pharmacother 46:219-28. 2012

Collaborators

Detail Information

Publications3

  1. doi request reprint Cephalosporin-induced leukopenia following rechallenge with cefoxitin
    Craig B Whitman
    Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA 19104, USA
    Ann Pharmacother 42:1327-32. 2008
    ..To describe a case of cefazolin-induced leukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin...
  2. doi request reprint Possible case of nafcillin-induced acute interstitial nephritis
    Craig B Whitman
    Philadelphia College of Pharmacy, University of the Sciences, 600 South 43rd Street, Philadelphia, PA 19104, USA
    Am J Health Syst Pharm 69:1049-53. 2012
    ..To report a case of acute interstitial nephritis (AIN) secondary to nafcillin...
  3. doi request reprint Fidaxomicin for the treatment of Clostridium difficile infections
    Craig B Whitman
    Philadelphia College of Pharmacy, University of the Sciences, PA, USA
    Ann Pharmacother 46:219-28. 2012
    ..To evaluate the pharmacology, microbiology, safety, and efficacy of fidaxomicin for treatment of Clostridium difficile infections (CDI)...